Most Recent

It's a Cell-Eat-Cell World

By Jef Akst | August 1, 2011

For more than 100 years, pathologists have observed cancer cells engulfing other live cells, but scientists are only now beginning to understand how it happens and what it means for tumorigenesis.

21 Comments

image: Make Mine Rare

Make Mine Rare

By Megan Scudellari | August 1, 2011

With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.

6 Comments

image: Memory Aid

Memory Aid

By Richard P. Grant | August 1, 2011

Editor's Choice in Neuroscience

3 Comments

image: Toads

Toads

By Richard P. Sloan | August 1, 2011

Ascribing benefits to the experience of devastating illness or trauma is fraught with hidden dangers.

33 Comments

image: Capsule Reviews

Capsule Reviews

By Bob Grant | August 1, 2011

First Life, Radioactivity, Brain Bugs, Life of Earth

0 Comments

Contributors

August 1, 2011

Meet some of the people featured in the August 2011 issue of The Scientist.

0 Comments

image: Powering Clinical Trials

Powering Clinical Trials

By Jef Akst | August 1, 2011

To ensure high-quality clinical trials of a malaria vaccine, organizers in rural Africa must first upgrade electrical and research infrastructures.

9 Comments

image: Sharing the Bounty

Sharing the Bounty

By Michelle G. Rooks and Wendy S. Garrett | August 1, 2011

Gut bacteria may be the missing piece that explains the connection between diet and cancer risk.

24 Comments

image: Stem Cells Hit Reverse

Stem Cells Hit Reverse

By Tia Ghose | July 31, 2011

A transcription factor can make adult stem cells behave like fetal stem cells.

0 Comments

image: A Universal Flu Vaccine?

A Universal Flu Vaccine?

By Jef Akst | July 28, 2011

An antibody that binds 16 different flu viruses offers hope for the long-sought universal vaccine.

3 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. North American Universities Increasingly Cancel Publisher Packages
  4. CRISPR Efficiency Tied to Cancer-Causing Process